AG

Anusha Gante

Active Director Director DIN 11877131
DIN 11877131 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Anusha Gante

Anusha Gante is a Director at Nirvana Pharma Global Private Limited (since 2026).

DIN 11877131
Primary Designation Director
First Appointment 07 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Aug 20262026Active

Board colleagues of Anusha Gante

NameDINCompanyDesignation
Govinda Rajulu Shrinija11877132Nirvana Pharma Global Private LimitedDirector
Krishna Chaitanya MadhavarapuNirvana Pharma Global Private LimitedIndividual Subscriber
Lakshmipriya Vegivinti11877130Nirvana Pharma Global Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nirvana Pharma Global Private Limited
Premium access

Shareholding and investment profile for Anusha Gante

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anusha Gante

Anusha Gante currently holds 1 directorship: Nirvana Pharma Global Private Limited (Director, since 07 Aug 2026).

Anusha Gante was first appointed on 07 Aug 2026 as Director at Nirvana Pharma Global Private Limited.

The current boards of Anusha Gante's companies include Govinda Rajulu Shrinija (Nirvana Pharma Global Private Limited), Krishna Chaitanya Madhavarapu (Nirvana Pharma Global Private Limited), Lakshmipriya Vegivinti (Nirvana Pharma Global Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available